The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Related News Articles

Headline
Microsoft July 22 released an update on the ongoing cyberattacks to SharePoint servers used within organizations, attributing the incidents to China-based…
Headline
The FBI, Cybersecurity and Infrastructure Security Agency, Department of Health and Human Services, and Multi-State Information Sharing and Analysis Center…
Headline
Microsoft July 19 issued an alert about active attacks from vulnerabilities targeting SharePoint servers used within organizations. The incidents have not…
Headline
In his latest AHA Cyber and Risk Intel blog, Scott Gee, AHA deputy national advisor for cybersecurity and risk, explains how hospitals can prepare for and…
AHA Cyber Intel
In today’s heightened threat environment, driven by domestic and geopolitical issues, it is more critical than ever for hospitals to prepare for and mitigate…
Headline
In a statement submitted to the Senate Health, Education, Labor and Pensions Committee for a hearing today on health care cybersecurity and patient privacy,…